Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 4,443 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reports Clear all

Conditions: Craniotomy
Interventions: Tetranite for Cranial Flap Fixation (TN-CFF); Device
Lead sponsor: RevBio; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts • Memphis, Tennessee

Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis
Interventions: Tappt; Device
Lead sponsor: Mercy Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: New Orleans, Louisiana • Chevy Chase, Maryland • New York, New York + 3 more

Conditions: Hypertension
Interventions: Hypertension medication algorithm, Impedance Cardiography; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hepatitis C
Interventions: DBS TaT, Usual Care; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Critical Illness, Palliative Care, Older Adults, Informal Caregivers, Care Delivery Model
Interventions: ICUconnect, Usual care; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Birmingham, Alabama • New York, New York • Durham, North Carolina + 1 more

Conditions: Neurocognitive Disorders
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Breast Cancer, Corpus Uteri Cancer, Ovary Cancer, Pancreas Cancer, Other Female Genital Malignant Neoplasms
Interventions: INSPIRE (INtegrating Systematic PatIent-Reported Evaluations), Capture of patient-reported outcomes, Enhanced Clinician Awareness; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 2,748 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 3
States / cities: Birmingham, Alabama • Los Angeles, California • Oklahoma City, Oklahoma

Conditions: Aging
Interventions: VM @ Home Usability; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Dedham, Massachusetts • Weston, Massachusetts

Conditions: Pelvic Pain
Interventions: Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 35 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Heart Failure，Congestive
Interventions: Sano Patient Medication Profile; Diagnostic Test
Lead sponsor: Precera Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Carpal Tunnel Syndrome
Interventions: Interossei Lumbricals Neuro Interface, Standard QWERTY keyboard; Device
Lead sponsor: Finger Relief; Other
Eligibility: 12 Years to 85 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2008
U.S. locations: 1
States / cities: Springfield, Virginia

Conditions: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions
Interventions: Patient Reported Outcome Measure (PROM), Comprehensive Medication Review (CMR), Communications between oncology and primary care pharmacists; Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cannabis Use Disorder
Interventions: Motivational Enhancement Therapy plus Ecological Momentary Intervention, Enhanced Usual Care; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 26 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer
Interventions: Personality Feedback Self-Management Intervention; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older
Enrollment: 419 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Obesity & Overweight, Diabetes (DM)
Interventions: Glucagon-Like Peptide-1 Agonist (GLP-1); Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Fall, Motivation, Behavior, Coping Behavior
Interventions: Motivational Interviewing; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 65 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Overweight, Obesity
Interventions: Deaf Weight Wise program; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 40 Years to 70 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Sleep Disordered Breathing, Tetraplegia
Interventions: PAP Device Procedure; Procedure
Lead sponsor: Mark S. Nash, Ph.D., FACSM; Other
Eligibility: 18 Years to 65 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cancer, Severe Major Depression, Schizophrenia, Bipolar Disorder, Lung Cancer, Breast Cancer, Head and Neck Cancer, Gastrointestinal Cancer
Interventions: Proactive Psychiatry Consultation (PPC), Enhanced Usual Care (EUC); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Geriatric Disorder, Cancer, Patient Fall
Interventions: Stepping On Education Program, Home visit, Patient Questionnaire, Mini-Balance Evaluation Systems Test, GAITRite, Precise measure of movement testing; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 70 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Sickle Cell Disease
Interventions: lovo-cel; Genetic
Lead sponsor: Genetix Biotherapeutics Inc.; Industry
Eligibility: 12 Years to 50 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 11
States / cities: Birmingham, Alabama • Oakland, California • Atlanta, Georgia + 8 more

Conditions: Opioid Use, Opioid Dependence, Opioid Misuse, Post-Surgical Complication
Interventions: Empowering Patient to Steer Their Pain Management After Surgery, Provider-facing Prescription Aid; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 89 Years
Enrollment: 711 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Sexual Assault, Sexual Harassment
Interventions: Junior Enlisted Component, Leadership Component, Social Marketing Campaign; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prostate Cancer
Interventions: Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog, External Beam Radiotherapy; Drug · Radiation
Lead sponsor: University of Sydney; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 19
States / cities: Boston, Massachusetts • Brighton, Massachusetts • Burlington, Massachusetts + 15 more

Search by objective public record fields.

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Tailored to You (TTY) Pilot Study

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

Improving Needs Among Older Adults

Development of the Pediatric Neurocognitive Functioning Questionnaire

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

Integrated Web-Based Customer Engagement, Physical Exercise, and Coaching Platform for Older Adults

Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

Comprehensive Medication Monitoring on Heart Failure Patient Outcomes

Study Protocol for CTS and Keyboard Controlled Randomized Trial

Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications

Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults

Personality and Cancer Care Study

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Engaging Older Adults in Fall Prevention Using Motivational Interviewing (MI)

Study of a Healthy Lifestyle Intervention for Deaf Adults Who Are Overweight or Obese

Sleep Disordered Breathing

Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer

Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Efficiency And Quality In Post-Surgical Pain Therapy After Discharge

Code of Respect (X-CoRe): Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate